Q4 2020 Holdings
Filed 2021-02-16 | 96 holdings | $860.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Avantor Inc(AVTR) | COM | 05352A100 | $184.9M | 6,566,700 | 21.5% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $151.8M | 1,787,358 | 17.6% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $145.3M | 1,356,000 | 16.9% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $87.1M | 992,900 | 10.1% |
| Bausch Health COS Inc(BHC) | COM | 071734107 | $41.0M | 1,972,000 | 4.8% |
| Anika Therapeutics Inc(ANIK) | COM | 035255108 | $33.1M | 731,000 | 3.8% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $28.9M | 1,607,000 | 3.4% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $28.2M | 527,600 | 3.3% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $27.7M | 2,000,000 | 3.2% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $26.9M | 1,850,873 | 3.1% |
| Atricure Inc(ATRC) | COM | 04963C209 | $24.9M | 446,600 | 2.9% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $24.8M | 1,239,000 | 2.9% |
| Certara Inc(CERT) | COM | 15687V109 | $13.6M | 404,663 | 1.6% |
| Codexis Inc(CDXS) | COM | 192005106 | $13.1M | 600,000 | 1.5% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $10.1M | 150,000 | 1.2% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $9.8M | 1,435,000 | 1.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $5.8M | 519,645 | 0.7% |
| Annexon Inc(ANNX) | COM | 03589W102 | $1.8M | 70,000 | 0.2% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $136.8K | 810,500 | 0.0% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $115.0K | 2,300,000 | 0.0% |
| Maravai Lifesciences Hldgs I(MRVI) | COM CL A | 56600D107 | $96.7K | 3,445,772 | 0.0% |
| Quest Diagnostic Inc(DGX) | COM | 74834L100 | $94.4K | 792,100 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $85.5K | 1,169,300 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $83.5K | 380,000 | 0.0% |
| I MAB(NBP) | SPONSORED ADS | 44975P103 | $75.0K | 1,591,000 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $73.6K | 3,308,000 | 0.0% |
| Biogen IncCall | COM | 09062X903 | $60.7K | 248,100 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $59.0K | 1,135,000 | 0.0% |
| Change Healthcare Inc(CHNGUSD) | COM | 15912K100 | $57.5K | 3,082,100 | 0.0% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $49.2K | 938,813 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $47.8K | 479,800 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $47.7K | 621,000 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $46.9K | 757,000 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $46.9K | 3,185,200 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN)Call | COM | G11196105 | $44.7K | 521,100 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $44.3K | 774,000 | 0.0% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $43.3K | 808,000 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $42.2K | 491,800 | 0.0% |
| Organogenesis Hldgs Inc(ORGO) | COM | 68621F102 | $41.6K | 5,521,500 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $39.7K | 9,570,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $38.3K | 299,000 | 0.0% |
| Sarepta Tehrapeutics Inc(SRPT) | COM | 803607100 | $37.1K | 217,400 | 0.0% |
| Athira Pharma Inc | COM | 04746L104 | $35.8K | 1,043,873 | 0.0% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $35.3K | 301,000 | 0.0% |
| Catalent Inc(CTLTEUR) | COM | 148806102 | $35.1K | 337,000 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $34.8K | 147,300 | 0.0% |
| Sigilon Therapeutics Inc | COM | 82657L107 | $33.0K | 688,000 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $32.7K | 247,000 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $30.5K | 2,558,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $28.8K | 300,000 | 0.0% |